H

Helixmith Co Ltd
KOSDAQ:084990

Watchlist Manager
Helixmith Co Ltd
KOSDAQ:084990
Watchlist
Price: 5 950 KRW -5.1% Market Closed
Market Cap: 274.2B KRW

Helixmith Co Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Helixmith Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
H
Helixmith Co Ltd
KOSDAQ:084990
Cash from Operating Activities
-â‚©9B
CAGR 3-Years
41%
CAGR 5-Years
28%
CAGR 10-Years
-39%
Celltrion Inc
KRX:068270
Cash from Operating Activities
â‚©812.1B
CAGR 3-Years
42%
CAGR 5-Years
22%
CAGR 10-Years
34%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Operating Activities
â‚©162.4B
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
26%
Alteogen Inc
KOSDAQ:196170
Cash from Operating Activities
â‚©82.2B
CAGR 3-Years
N/A
CAGR 5-Years
30%
CAGR 10-Years
52%
A
ABL Bio Inc
KOSDAQ:298380
Cash from Operating Activities
-â‚©33.2B
CAGR 3-Years
2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
D
DND PharmaTech Inc
KOSDAQ:347850
Cash from Operating Activities
-â‚©21.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Helixmith Co Ltd
Glance View

Market Cap
274B KRW
Industry
Biotechnology

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-29. The firm operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Intrinsic Value
972.79 KRW
Overvaluation 84%
Intrinsic Value
Price
H

See Also

What is Helixmith Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-9B KRW

Based on the financial report for Jun 30, 2025, Helixmith Co Ltd's Cash from Operating Activities amounts to -9B KRW.

What is Helixmith Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-39%

Over the last year, the Cash from Operating Activities growth was 55%. The average annual Cash from Operating Activities growth rates for Helixmith Co Ltd have been 41% over the past three years , 28% over the past five years , and -39% over the past ten years .

Back to Top